AngioDynamics, Inc. — Earnings Quality Grade F
ANGO · Healthcare
Major red flags
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 54 days, change +1 days YoY
AR growth -1.7% vs revenue growth -3.8%
Revenue -3.8%, CFFO 64.0%. Cash follows revenue
Expense Quality
Inventory 2.3% vs COGS -9.7%. Normal
CapEx growth -22.6% vs revenue -3.8%. Normal
SG&A/Gross Profit = 92.1%, exceeds 70%
Gross margin 53.9%, change +3.0pp. Stable
Cash Flow Quality
CFFO < Net Income for 3 consecutive years
Small-cap context: Small-cap CFFO/NI often diverges from working-capital swings, not necessarily manipulation.
FCF is negative ($-0.0B)
Accruals ratio = -8.5%. Low accruals
Insufficient data
Balance Sheet Health
Goodwill+Intangibles $0.1B = 38% of equity
Insufficient data
Other assets -8.5% vs revenue -3.8%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions negative for 3 years
Small-cap context: A single acquisition on a small balance sheet can trip serial-acquirer logic.
Goodwill+Intangibles change -11% YoY. Normal
Manipulation Score
M-Score = -2.91 (< -2.22). Unlikely manipulator
Portfolio monitoring
Monitor ANGO continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25